BioCentury
ARTICLE | Financial News

Immuron raises $6.1M in follow-on and lists on NASDAQ

June 16, 2017 5:05 AM UTC

On June 8, polyclonal antibody company Immuron Ltd. (ASX:IMC; NASDAQ:IMRN) raised $6.1 million through the sale of 610,000 ADSs at $10 in a follow-on to transfer its listing to NASDAQ from the Pink S...

BCIQ Company Profiles

Immuron Ltd.